Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5 and XIST expression profiles in diffuse large B-cell lymphoma: association with R-CHOP responsiveness

22 Jan 2021

Abstract excerpt

The reliable identification of diffuse large B-cell lymphoma (DLBCL)-specific targets owns huge implications for its diagnosis and treatment. Long non-coding RNAs (lncRNAs) are implicated in DLBCL pathogenesis; however, circulating DLBCL-related lncRNAs are barely investigated. We investigated plasma lncRNAs; HOTAIR, Linc-p21, GAS5 and XIST as biomarkers for DLBCL diagnosis and responsiveness to R-CHOP therapy....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33483590
DOI: 10.1038/s41598-021-81715-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5 and XIST expression profiles in diffuse large B-cell lymphoma: association with R-CHOP responsivenessPMID 33483590Read ↗

Long noncoding RNA XIST: a novel independent prognostic biomarker for patients with ABC-DLBCL receiving R-CHOP treatmentSemantic proximity Read ↗

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosisSemantic proximity Read ↗

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCLSemantic proximity Read ↗

LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapySemantic proximity Read ↗

A prognostic signature based on ectopic reactivation of eight tissue-specific genes in Diffuse Large B Cell Lymphoma.Semantic proximity Read ↗

Non-Coding RNAs in Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

The PVT1, HULC, and HOTTIP expression changes due to treatment in Diffuse Large B-cell lymphomaSemantic proximity Read ↗

Gene expression-based risk score in diffuse large B-cell lymphoma.Semantic proximity Read ↗

LymphGen-Sig: Integrating genetic and transcriptional states to predict therapeutic response in DLBCLSemantic proximity Read ↗

Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphomaSemantic proximity Read ↗

Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.